Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Clinical trial NCT03446573 · COMPLETED
Trial details
- NCT number
- NCT03446573
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-18
- Primary completion
- 2019-05-20
- Enrollment
- 743
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.